[1]
|
Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.
https://doi.org/10.3322/caac.21492
|
[2]
|
Rodriguez-Paredes, M. and Esteller, M. (2011) Cancer Epigenetics Reaches Mainstream Oncology. Nature Medicine, 17, 330-339. https://doi.org/10.1038/nm.2305
|
[3]
|
Jin, Z. and Liu, Y. (2018) DNA Methylation in Human Diseases. Genes and Diseases, 5, 1-8.
https://doi.org/10.1016/j.gendis.2018.01.002
|
[4]
|
Hu, X.T. and He, C. (2013) Recent Progress in the Study of Methylated Tumor Suppressor Genes in Gastric Cancer. Chinese Journal of Cancer, 32, 31-41. https://doi.org/10.5732/cjc.011.10175
|
[5]
|
Wang, K., Liang, Q., Li, X., et al. (2016) MDGA2 Is a Novel Tumour Suppressor Cooperating with DMAP1 in Gastric Cancer and Is Associated with Disease Outcome. Gut, 65, 1619-1631. https://doi.org/10.1136/gutjnl-2015-309276
|
[6]
|
Ehrlich, M. and Lacey, M. (2013) DNA Hypomethylation and Hemimethylation in Cancer. Advances in Experimental Medicine and Biology, 754, 31-56. https://doi.org/10.1007/978-1-4419-9967-2_2
|
[7]
|
Gaudet, F., Hodgson, J.G., Eden, A., et al. (2003) Induction of Tumors in Mice by Genomic Hypomethylation. Science, 300, 489-492. https://doi.org/10.1126/science.1083558
|
[8]
|
Leodolter, A., Alonso, S., Gonzalez, B., et al. (2015) Somatic DNA Hypomethylation in H. pylori-Associated High-Risk Gastritis and Gastric Cancer: Enhanced Somatic Hypomethylation Associates with Advanced Stage Cancer. Clinical and Translational Gastroenterology, 6, e85. https://doi.org/10.1038/ctg.2015.14
|
[9]
|
Yang, J., Wei, X., Wu, Q., et al. (2011) Clinical Significance of the Expression of DNA Methyltransferase Proteins in Gastric Cancer. Molecular Medicine Reports, 4, 1139-1143.
|
[10]
|
Yang, X.X., He, X.Q., Li, F.X., et al. (2012) Risk-Association of DNA Methyltransferases Polymorphisms with Gastric Cancer in the Southern Chinese Population. International Journal of Molecular Sciences, 13, 8364-8378.
https://doi.org/10.3390/ijms13078364
|
[11]
|
Jurkowska, R.Z., Jurkowski, T.P. and Jeltsch, A. (2011) Structure and Function of Mammalian DNA Methyltransferases. Chembiochem, 12, 206-222. https://doi.org/10.1002/cbic.201000195
|
[12]
|
Jobe, E.M., Gao, Y., Eisinger, B.E., et al. (2017) Methyl-CpG-Binding Protein MBD1 Regulates Neuronal Lineage Commitment through Maintaining Adult Neural Stem Cell Identity. Journal of Neuroscience, 37, 523-536.
https://doi.org/10.1523/JNEUROSCI.1075-16.2016
|
[13]
|
Wu, Y.C., Lv, P., Han, J., et al. (2014) Enhanced Serum Methylated p16 DNAs Is Associated with the Progression of Gastric Cancer. International Journal of Clinical and Experimental Pathology, 7, 1553-1562.
|
[14]
|
白艳丽, 金建军, 刘献民, 等. 胃癌p16基因启动子区甲基化状态的研究[J]. 中国实用医药, 2016, 11(14): 56-57.
|
[15]
|
Peng, D., Zhang, H. and Sun, G. (2014) The Relationship between P16 Gene Promoter Methylation and Gastric Cancer: A Meta-Analysis Based on Chinese Patients. Journal of Cancer Research and Therapeutics, 10, 292-295.
https://doi.org/10.4103/0973-1482.151535
|
[16]
|
Lim, H.K., Park, J.M., Chi, K.C., et al. (2013) Disappearance of Serum Methylated p16 Indicates Longer Survival in Patients with Gastric Cancer. Journal of Gastric Cancer, 13, 157-163. https://doi.org/10.5230/jgc.2013.13.3.157
|
[17]
|
Wen, J., Zheng, T., Hu, K., et al. (2017) Promoter Methylation of Tumor-Related Genes as a Potential Biomarker Using Blood Samples for Gastric Cancer Detection. Oncotarget, 8, 77783-77793.
https://doi.org/10.18632/oncotarget.20782
|
[18]
|
Sakakura, C., Hamada, T., Miyagawa, K., et al. (2009) Quantitative Analysis of Tumor-Derived Methylated RUNX3 Sequences in the Serum of Gastric Cancer Patients. Anticancer Research, 29, 2619-2625.
|
[19]
|
Yi, K.D., Kyoon, J.J., Kyu, P.Y., et al. (2007) E-Cadherin Expression in Early Gastric Carcinoma and Correlation with Lymph Node Metastasis. Journal of Surgical Oncology, 96, 429-435. https://doi.org/10.1002/jso.20732
|
[20]
|
Yu, Q.M., Wang, X.B., Luo, J., et al. (2012) CDH1 Methylation in Preoperative Peritoneal Washes Is an Independent Prognostic Factor for Gastric Cancer. Journal of Surgical Oncology, 106, 765-771. https://doi.org/10.1002/jso.23116
|
[21]
|
Shen, S., Chen, X., Li, H., et al. (2018) MLH1 Promoter Methylation and Prediction/Prognosis of Gastric Cancer: A Systematic Review and Meta and Bioinformatic Analysis. Journal of Cancer, 9, 1932-1942.
https://doi.org/10.7150/jca.23284
|
[22]
|
Li, Y., Yang, Y., Lu, Y., et al. (2015) Predictive Value of CHFR and MLH1 Methylation in Human Gastric Cancer. Gastric Cancer, 18, 280-287. https://doi.org/10.1007/s10120-014-0370-2
|
[23]
|
Shigeyasu, K., Nagasaka, T., Mori, Y., et al. (2015) Clinical Significance of MLH1 Methylation and CpG Island Methylator Phenotype as Prognostic Markers in Patients with Gastric Cancer. PLoS ONE, 10, e130409.
https://doi.org/10.1371/journal.pone.0130409
|
[24]
|
蒋伟, 张健锋, 毛振彪. 胃癌组织及外周血中CDX2基因甲基化的关系及其临床意义[J]. 交通医学, 2015, 29(4): 329-332.
|
[25]
|
Liu, L. and Yang, X. (2015) Implication of Reprimo and hMLH1 Gene Methylation in Early Diagnosis of Gastric Carcinoma. International Journal of Clinical and Experimental Pathology, 8, 14977-14982.
|
[26]
|
Pimson, C., Ekalaksananan, T., Pientong, C., et al. (2016) Aberrant Methylation of PCDH10 and RASSF1A Genes in Blood Samples for Non-Invasive Diagnosis and Prognostic Assessment of Gastric Cancer. PeerJ, 4, e2112.
https://doi.org/10.7717/peerj.2112
|
[27]
|
Wang, G., Zhang, W., Zhou, B., et al. (2015) The Diagnosis Value of Promoter Methylation of UCHL1 in the Serum for Progression of Gastric Cancer. BioMed Research International, 2015, Article ID: 741030.
https://doi.org/10.1155/2015/741030
|
[28]
|
Hu, W., Zheng, W., Liu, Q., et al. (2017) Diagnostic Accuracy of DNA Methylation in Detection of Gastric Cancer: A Meta-Analysis. Oncotarget, 8, 113142-113152. https://doi.org/10.18632/oncotarget.22613
|
[29]
|
Lin, Z., Luo, M., Chen, X., et al. (2017) Combined Detection of Plasma ZIC1, HOXD10 and RUNX3 Methylation Is a Promising Strategy for Early Detection of Gastric Cancer and Precancerous Lesions. Journal of Cancer, 8, 1038-1044.
https://doi.org/10.7150/jca.18169
|
[30]
|
Wang, Y.B. and Ba, C.F. (2012) Promoter Methylation of Esophageal Cancer-Related Gene 4 in Gastric Cancer Tissue and Its Clinical Significance. Hepatogastroenterology, 59, 1696-1698.
|
[31]
|
Pirini, F., Noazin, S., Jahuira-Arias, M.H., et al. (2017) Early Detection of Gastric Cancer Using Global, Genome-Wide and IRF4, ELMO1, CLIP4 and MSC DNA Methylation in Endoscopic Biopsies. Oncotarget, 8, 38501-38516.
https://doi.org/10.18632/oncotarget.16258
|
[32]
|
Oishi, Y., Watanabe, Y., Yoshida, Y., et al. (2012) Hypermethylation of Sox17 Gene Is Useful as a Molecular Diagnostic Application in Early Gastric Cancer. Tumor Biology, 33, 383-393. https://doi.org/10.1007/s13277-011-0278-y
|
[33]
|
Baylin, S.B. (2005) DNA Methylation and Gene Silencing in Cancer. Nature Clinical Practice Oncology, 2, S4-S11.
https://doi.org/10.1038/ncponc0354
|
[34]
|
Piekarz, R.L. and Bates, S.E. (2009) Epigenetic Modifiers: Basic Understanding and Clinical Development. Clinical Cancer Research, 15, 3918-3926. https://doi.org/10.1158/1078-0432.CCR-08-2788
|
[35]
|
Deng, P., Chang, X.J., Gao, Z.M., et al. (2018) Downregulation and DNA Methylation of ECRG4 in Gastric Cancer. OncoTargets and Therapy, 11, 4019-4028. https://doi.org/10.2147/OTT.S161200
|
[36]
|
Yang, F., He, K., Huang, L., et al. (2017) Casticin Inhibits the Activity of Transcription Factor Sp1 and the Methylation of RECK in MGC803 Gastric Cancer Cells. Experimental and Therapeutic Medicine, 13, 745-750.
https://doi.org/10.3892/etm.2016.4003
|
[37]
|
Wu, F.L., Li, R.T., Yang, M., et al. (2015) Gelatinases-Stimuli Nanoparticles Encapsulating 5-Fluorouridine and 5-Aza-2’-deoxycytidine Enhance the Sensitivity of Gastric Cancer Cells to Chemical Therapeutics. Cancer Letters, 363, 7-16. https://doi.org/10.1016/j.canlet.2015.01.006
|
[38]
|
Sugita, H., Iida, S., Inokuchi, M., et al. (2011) Methylation of BNIP3 and DAPK Indicates Lower Response to Chemotherapy and Poor Prognosis in Gastric Cancer. Oncology Reports, 25, 513-518.
https://doi.org/10.3892/or.2010.1085
|
[39]
|
Joo, J.K., Kim, S.H., Kim, H.G., et al. (2010) CpG Methylation of Transcription Factor 4 in Gastric Carcinoma. Annals of Surgical Oncology, 17, 3344-3353. https://doi.org/10.1245/s10434-010-1131-z
|
[40]
|
Oh, J.H., Jung, S.H., Hong, S.J., et al. (2015) DNA Methylation as Surrogate Marker for Gastric Cancer. Journal of Cancer Prevention, 20, 172-178. https://doi.org/10.15430/JCP.2015.20.3.172
|
[41]
|
Yang, W., Mok, M.T., Li, M.S., et al. (2016) Epigenetic Silencing of GDF1 Disrupts SMAD Signaling to Reinforce Gastric Cancer Development. Oncogene, 35, 2133-2144. https://doi.org/10.1038/onc.2015.276
|
[42]
|
Yuan, R., Wang, G., Xu, Z., et al. (2016) Up-Regulated Circulating miR-106a by DNA Methylation Promised a Potential Diagnostic and Prognostic Marker for Gastric Cancer. Anti-Cancer Agents in Medicinal Chemistry, 16, 1093-1100.
https://doi.org/10.2174/1871520615666150716110657
|
[43]
|
Shigaki, H., Baba, Y., Watanabe, M., et al. (2013) LINE-1 Hypomethylation in Gastric Cancer, Detected by Bisulfite Pyrosequencing, Is Associated with Poor Prognosis. Gastric Cancer, 16, 480-487.
https://doi.org/10.1007/s10120-012-0209-7
|
[44]
|
Hu, C., Zhou, Y., Liu, C., et al. (2018) A Novel Scoring System for Gastric Cancer Risk Assessment Based on the Expression of Three CLIP4 DNA Methylation-Associated Genes. International Journal of Oncology, 53, 633-643.
https://doi.org/10.3892/ijo.2018.4433
|
[45]
|
Xu, X., Chang, X., Li, Z., et al. (2015) Aberrant SOX11 Promoter Methylation Is Associated with Poor Prognosis in Gastric Cancer. Cellular Oncology, 38, 183-194. https://doi.org/10.1007/s13402-015-0219-7
|
[46]
|
Sui, B.Q., Zhang, C.D., Liu, J.C., et al. (2018) HOXB13 Expression and Promoter Methylation as a Candidate Biomarker in Gastric Cancer. Oncology Letters, 15, 8833-8840. https://doi.org/10.3892/ol.2018.8371
|
[47]
|
Harada, H., Hosoda, K., Moriya, H., et al. (2019) Cancer-Specific Promoter DNA Methylation of Cysteine Dioxygenase Type 1 (CDO1) Gene as an Important Prognostic Biomarker of Gastric Cancer. PLoS ONE, 14, e214872.
https://doi.org/10.1371/journal.pone.0214872
|
[48]
|
Deng, J., Liang, H., Dong, Q., et al. (2014) The Survival Decrease in Gastric Cancer Is Associated with the Methylation of B-Cell CLL/Lymphoma 6 Member B Promoter. Open Biology, 4, Article ID: 140067.
https://doi.org/10.1098/rsob.140067
|
[49]
|
Wu, L., Zhang, C., Wang, X., et al. (2016) Methylation of ASC/TMS1 Promoter Is Associated with Poor Prognosis of Patients with Gastric Cancer. Clinical and Translational Oncology, 18, 296-303.
https://doi.org/10.1007/s12094-015-1367-y
|
[50]
|
Zhang, J., Dai, W. and Yang, X. (2015) Methylation Status of TRAF2 Is Associated with the Diagnosis and Prognosis of Gastric Cancer. International Journal of Clinical and Experimental Pathology, 8, 14228-14234.
|